// App-Quantinova.ai

7573 : Cutaneous toxicity secondary to erlotinib therapy in patients with non-small cell lung cancer in the NCIC CTG BR.21 study: Time course and correlation with survival.

Researchers

Presenter

  • Roman Perez-Soler

Principal Investigators

  • Larry Leon

  • Slawomir Wojtowicz-Praga

Medical Centers

  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Erlotinib hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved